World News Insights
1-3 Minute Gist
Search, personalize, or simply browse. Follow the world around you from gist and context to insights.
Who we are | Our Credo | Ways of using Lyrarc | FAQ | Send Feedback | First Letter From the Editor
Sign up. It's free and easy to use
Create an account
to personalize your feed of articles and topics.
All Topics Article
J&J Penalty May Total $2.2 Billion
Keywords:
J&J and the settlement with the U.S. Justice Department for off-label marketing of drug Risperdal
04/10/2007
Grouped Articles
Johnson & Johnson to Pay $2.2 Billion to Settle U.S. Probes
Wall Street Journal 11/05/2013
J&J Close to Settling Off-Label Probes
Wall Street Journal 06/21/2012
Anemia drug made billions, but at what cost? - The Washington Post
Washington Post 07/20/2012
FDA Cancer Czar Stirs Debate On Agency's Role
Wall Street Journal 03/12/2008
Stronger Warnings on 3 Drugs for Anemia
New York Times 11/09/2007
Amgen's Star Fades Amid Safety Questions
Wall Street Journal 04/10/2007
J&J marketing practices
07/09/2010
Grouped Articles
J&J Starts Disclosing Drug Unit's Payments to Doctors
Wall Street Journal 07/09/2010
Johnson & Johnson to Settle Charge Over Risperdal Marketing
New York Times 08/09/2011
Judge Orders J&J to Pay $1.2 Billion
Wall Street Journal 04/12/2012
J&J Penalty May Total $2.2 Billion
Wall Street Journal 07/19/2012
Wall Street Journal 08/02/2012
J&J's DePuy Orthopaedics unit and mass litigation
07/08/2011
Grouped Articles
Hip Joints Set Off New Rush to Court
Wall Street Journal 07/08/2011
J&J Penalty May Total $2.2 Billion
Wall Street Journal 07/19/2012
J&J legal settlements
04/16/2011
Grouped Articles
Johnson & Johnson to Pay $2.2 Billion to Settle U.S. Probes
Wall Street Journal 11/05/2013
J&J to Pay at Least $2.5 Billion in Hip Settlement
Wall Street Journal 11/20/2013
Rivals Resolve Dispute Over Drug
Wall Street Journal 04/16/2011
Hip Joints Set Off New Rush to Court
Wall Street Journal 07/08/2011
Johnson & Johnson to Settle Charge Over Risperdal Marketing
New York Times 08/09/2011
Wall Street Journal 01/25/2012
J&J performance
08/30/2010
Grouped Articles
J&J Likely Gets Better Grade Than Deserved
Wall Street Journal 07/15/2013
Johnson & Johnson to Pay $2.2 Billion to Settle U.S. Probes
Wall Street Journal 11/05/2013
J&J Chief Tends Corporate Wounds
Wall Street Journal 08/30/2010
J&J Chief To Receive $143 Million Farewell
Wall Street Journal 03/15/2012
Sales of Johnson & Johnson's New Hepatitis C Drug Soar
Wall Street Journal 04/16/2014
J&J’s Earnings Jump on Higher Drug Sales
Wall Street Journal 10/15/2014
We took a different way to help millions around the world build educated informed mindsets that affects and shapes their lives. For a future that is open, global and digital, with everyone having access to high quality information. We believe in the renewal of America, renewal of Europe, the renewal of India, the rest of Asia, Latin America and Africa. The renewal of our supply chains, health, education, infrastructure, as we rebuild our countries after the pandemic. Literacy and knowledge we believe cannot thrive and grow in a world of web bots, web crawlers, or AI. This requires human curiosity, human learning, and human imagination. We take as inspiration the saying- “One has to be free, and as broad as sky. One has to have a mind that is crystal clear, only then can truth shine in it.” Every contribution whether big or small is precious- in this crisis and ahead.
Support Lyrarc from as small as $1
Terms and Conditions | Copyright Policy | Privacy Policy | Contact Us